MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.gimo.2026.104372

Медицинская библиотека · Genetics in medicine open · 2026

Findings from comprehensive genome sequencing in the Canadian population: Results from the GENCOV Study.

Casalino Selina, Aujla Navneet, Frangione Erika, Mahajan Radhika, Di Iorio David, Fung Chun Yiu Jordan, Jayachandran Lochana, MacDonald Georgia, Morgan Gregory, Wolday Dawit, Young Juliet, Arnoldo Saranya, Bearss Erin, Binnie Alexandra, Borgundvaag Bjug, Chowdhary Sunakshi, Clausen Marc, Dagher Marc, Devine Luke, Dickson Brendan, Friedman Steven Marc, Gingras Anne-Claude, Goneau Lee W, Khan Zeeshan, Lapadula Elisa, Mazzulli Tony, McGeer Allison, McLeod Shelley L, Mighton Chloe, Pugh Trevor J, Richardson David, Scherer Stephen W, Simpson Jared, Stern Seth, Taher Ahmed, Strug Lisa J, Bombard Yvonne, Faghfoury Hanna, Greenfeld Elena, Hao Limin, Lebo Matthew, Lane William, Noor Abdul, Taher Jennifer, Lerner-Ellis Jordan, HostSeq Implementation Committee

СтатьяПеревод в очереди

Аннотация

PURPOSE: Opportunistic genome sequencing (GS) allows for the return of findings to clinical and research cohorts. We report on comprehensive GS results from the GENCOV study in Ontario, Canada.

METHODS

GS data were analyzed for clinically significant variants associated with monogenic disease and carrier status for autosomal recessive and X-linked conditions, pharmacogenomic variation, polygenic risk scores for common conditions, human leukocyte antigen and blood group genotypes, and genetic ancestry. GS results were summarized using descriptive statistics.

RESULTS

GS was completed on 1292 participants; 53% were female, 53% were 18 to 39 years old, and 816 (63%) were estimated to have European genetic ancestry. All (100%) had a variant associated with drug metabolism, 845 (65%) with increased polygenic risk scores, 735 (57%) with a risk-associated human leukocyte antigen genotype, and 857 (69%) and 91 (7%) with a rare red blood cell and/or platelet antigen, respectively. Of 851 who received reports, 261 (31%) had a variant associated with monogenic disease (178 or 21% were considered medically actionable) and 782 (92%) had at least one variant associated with carrier status.

CONCLUSION

Opportunistic GS demonstrated that many individuals harbor GS findings impacting their health, illustrating the potential of GS to inform personalized and proactive health care for Canadians.

Для цитирования: Casalino Selina, Aujla Navneet, Frangione Erika, Mahajan Radhika, Di Iorio David, Fung Chun Yiu Jordan, Jayachandran Lochana, MacDonald Georgia, Morgan Gregory, Wolday Dawit, Young Juliet, Arnoldo Saranya, Bearss Erin, Binnie Alexandra, Borgundvaag Bjug, Chowdhary Sunakshi, Clausen Marc, Dagher Marc, Devine Luke, Dickson Brendan, Friedman Steven Marc, Gingras Anne-Claude, Goneau Lee W, Khan Zeeshan, Lapadula Elisa, Mazzulli Tony, McGeer Allison, McLeod Shelley L, Mighton Chloe, Pugh Trevor J, Richardson David, Scherer Stephen W, Simpson Jared, Stern Seth, Taher Ahmed, Strug Lisa J, Bombard Yvonne, Faghfoury Hanna, Greenfeld Elena, Hao Limin, Lebo Matthew, Lane William, Noor Abdul, Taher Jennifer, Lerner-Ellis Jordan, HostSeq Implementation Committee. Findings from comprehensive genome sequencing in the Canadian population: Results from the GENCOV Study.. Genetics in medicine open. 2026. DOI: 10.1016/j.gimo.2026.104372.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.